Literature DB >> 35867826

C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7.

Yawei Ru1,2, Xiaojie Yan1,3, Bing Zhang3, Lili Song4, Qiqi Feng3, Chen Ye4, Zhili Zhou4, Zhenzhen Yang3, Yao Li3, Zhenjian Zhang4, Qianqian Li4, Wenyi Mi4, Cheng Dong1,3.   

Abstract

The exposed N-terminal or C-terminal residues of proteins can act, in cognate sequence contexts, as degradation signals (degrons) that are targeted by specific E3 ubiquitin ligases for proteasome-dependent degradation by N-degron or C-degron pathways. Here, we discovered a distinct C-degron pathway, termed the Gln/C-degron pathway, in which the B30.2 domain of E3 ubiquitin ligase TRIM7 (TRIM7B30.2) mediates the recognition of proteins bearing a C-terminal glutamine. By determining crystal structures of TRIM7B30.2 in complexes with various peptides, we show that TRIM7B30.2 forms a positively charged binding pocket to engage the "U"-shaped Gln/C-degron. The four C-terminal residues of a substrate play an important role in C-degron recognition, with C-terminal glutamine as the principal determinant. In vitro biochemical and cellular experiments were used to further analyze the substrate specificity and selective degradation of the Gln/C-degron by TRIM7.

Entities:  

Keywords:  E3 ubiquitin ligase; TRIM7; crystal structure; degron; protein degradation

Mesh:

Substances:

Year:  2022        PMID: 35867826      PMCID: PMC9335266          DOI: 10.1073/pnas.2203218119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  52 in total

Review 1.  Protein quality control and elimination of protein waste: the role of the ubiquitin-proteasome system.

Authors:  Ingo Amm; Thomas Sommer; Dieter H Wolf
Journal:  Biochim Biophys Acta       Date:  2013-07-10

Review 2.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

Review 3.  Bacterial E3 ligase effectors exploit host ubiquitin systems.

Authors:  Hiroshi Ashida; Chihiro Sasakawa
Journal:  Curr Opin Microbiol       Date:  2016-11-28       Impact factor: 7.934

Review 4.  Structural insights into the catalysis and regulation of E3 ubiquitin ligases.

Authors:  Lori Buetow; Danny T Huang
Journal:  Nat Rev Mol Cell Biol       Date:  2016-08-03       Impact factor: 94.444

5.  GNIP, a novel protein that binds and activates glycogenin, the self-glucosylating initiator of glycogen biosynthesis.

Authors:  Alexander V Skurat; Amy D Dietrich; Lanmin Zhai; Peter J Roach
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

Review 6.  The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy.

Authors:  Yong Tae Kwon; Aaron Ciechanover
Journal:  Trends Biochem Sci       Date:  2017-09-22       Impact factor: 13.807

Review 7.  Ubiquitin ligases in oncogenic transformation and cancer therapy.

Authors:  Daniela Senft; Jianfei Qi; Ze'ev A Ronai
Journal:  Nat Rev Cancer       Date:  2017-12-15       Impact factor: 60.716

8.  Crystal structure and mutational analysis of the human TRIM7 B30.2 domain provide insights into the molecular basis of its binding to glycogenin-1.

Authors:  Christian J Muñoz Sosa; Federico M Issoglio; María E Carrizo
Journal:  J Biol Chem       Date:  2021-05-11       Impact factor: 5.157

9.  The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases.

Authors:  Cheol-Sang Hwang; Anna Shemorry; Daniel Auerbach; Alexander Varshavsky
Journal:  Nat Cell Biol       Date:  2010-11-14       Impact factor: 28.824

Review 10.  Ubiquitin signaling in immune responses.

Authors:  Hongbo Hu; Shao-Cong Sun
Journal:  Cell Res       Date:  2016-03-25       Impact factor: 25.617

View more
  1 in total

1.  C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7.

Authors:  Yawei Ru; Xiaojie Yan; Bing Zhang; Lili Song; Qiqi Feng; Chen Ye; Zhili Zhou; Zhenzhen Yang; Yao Li; Zhenjian Zhang; Qianqian Li; Wenyi Mi; Cheng Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.